Plans review pediatric antidepressant use in wake of FDA label change

November 1, 2004

By withholding information about some antidepressant medications that cause an increase in suicidal tendencies among teenagers, the Food and Drug Administration (FDA) created heightened public concern about the value of antidepressants.